NASDAQ:ZEAL
Delisted
Zealand Pharma Stock News
$17.59
+0 (+0%)
At Close: Jan 27, 2023
The Emergence of Strong Weight Loss Drug Players
05:44pm, Tuesday, 05'th Mar 2024
Viking Therapeutics (VKTX) and Zealand Pharma report a successful phase 2 for weight loss drugs. Maurits Pot discusses the emergence of strong weight loss drug players.
Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results
02:00am, Tuesday, 20'th Feb 2024
Press Release – No. 2 / 2024 Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results Copenhagen, Denmark, February 20, 2024 – a Zealand Pha
Zealand Pharma A/S (ZEAL) Q3 2023 Earnings Call Transcript
12:15pm, Friday, 10'th Nov 2023
Zealand Pharma A/S (ZEAL) Q3 2023 Earnings Conference Call November 9, 2023 8:00 AM ET Company Participants Anna Krassowska - Vice President-Investor Relations Adam Steensberg - President & Chief Exec
Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results
11:05am, Monday, 14'th Aug 2023
Press Release – No. 9 / 2023 Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results Copenhagen, Denmark, August 14, 2023 – a Zealand Pharma A/
Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results
11:05am, Thursday, 04'th May 2023
Press Release– No. 3 / 2023 Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results Copenhagen, Denmark, May 4, 2023 – a Zealand Pharma A/S (CVR
Zealand Pharma A/S (ZEAL) Q4 2022 Earnings Call Transcript
12:55pm, Thursday, 02'nd Mar 2023
Zealand Pharma A/S (ZEAL) Q4 2022 Results Conference Call March 1, 2022 8:00 AM ET Company Participants Anna Krassowska - VP, IR Adam Steensberg - President, CEO Henriette Wennicke - CFO David Kendall
Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm CET (8 am ET) to Present Full Year Results for 2022
01:00am, Friday, 24'th Feb 2023
Press release – No. 1 / 2023
Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Call Transcript
04:42pm, Friday, 11'th Nov 2022
Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Anna Krassowska - Vice President, Investor Relations & Corporate Communications Adam Steen
Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022
04:00am, Thursday, 03'rd Nov 2022
Company announcement – No. 49 / 2022
Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
11:00am, Wednesday, 07'th Sep 2022
Press release – No. 4 / 2022
Zealand Pharma A/S (ZEAL) CEO Adam Steensberg on Q2 2022 Results - Earnings Call Transcript
01:16pm, Thursday, 11'th Aug 2022
Zealand Pharma A/S (ZEAL) Q2 2022 Earnings Conference Call August 11, 2022 10:00 AM ET Company Participants Anna Krassowska - VP of IR and Corporate Communications Adam Steensberg - President and CEO
Zealand Pharma AS (ZEAL) Stock Jumps 9.1%: Will It Continue to Soar?
10:07am, Thursday, 21'st Jul 2022
Zealand Pharma AS (ZEAL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength do
Zealand Pharma to Participate in Upcoming Investor Conferences
08:30am, Friday, 03'rd Jun 2022
Press release – No. 3 / 202 2
Why Zealand Pharma Shares Are Rising
10:41am, Thursday, 19'th May 2022
Zealand Pharma A/S - ADR (NASDAQ: ZEAL) shares are trading higher by 17.01% at $13.69 after the company announced the results from its phase 3 trial of Dasiglucagon in pediatric patients with congenit
Zealand Pharma's Dasiglucagon Aces Late-Stage Study In Pediatric Patients, Shares Move Higher
09:53am, Thursday, 19'th May 2022
Zealand Pharma A/S (NASDAQ: ZEAL) has announced topline results from its second Phase 3 trial of dasiglucagon in pediatric patients with congenital hyperinsulinism (CHI), a condition in which indiv